Intravenous drug use (IDU) poses severe health risks due to direct exposure to harmful substances and unhygienic practices. Common complications include infections like HIV, hepatitis B and C, and bacterial endocarditis. Non-sterile needles increase the risk of abscesses and vein damage. Long-term IDU often leads to systemic health issues, including cardiovascular and pulmonary complications. Harm reduction strategies, such as needle exchange programs and supervised injection sites, aim to mitigate these risks. Coupled with addiction treatment, these interventions improve health outcomes and reduce the societal burden of IDU-related complications.
Title : The root causes of addiction and mental health that are not being addressed: Where science meets recovery
John J Giordano, Life Enhancement Recovery Center, United States
Title : Consent: Yes means yes - unless it means no
Sam Vaknin, Commonwealth Institute of Advanced Professional Studies (CIAPS), United Kingdom
Title : Profiling kidney donors
Meni Koslowsky, Ariel University, Israel
Title : Beyond the diagnosis: Unlocking the adolescent brain – school neuropsychological case studies in addiction, mental health, learning, and evidence-based interventions
Ann Marie Leonard Zabel, Curry College and NEALAC Clinic , United States
Title : Beyond acute treatment: Integrating recovery residences in the addiction continuum of care
Adrienne Tichy, The Lodge at Delray Beach and Recovery Comes Home, United States